IMF Videos Search Content For Healthcare Professional (132) Healthcare Provider (132) Care Partner (67) Patient (67) Series - Any - ASCO/EHA (51) ASH (69) Ask Dr. Durie (23) Black Swan Research Initiative (2) Emerging Therapies (3) Facebook Live (6) IMWG (4) Living Well with Myeloma (2) Myeloma in a Minute (5) Myeloma Made Simple (5) Myeloma University (4) Patient & Family Webinar (1) Q&A (11) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (68) High-Risk Myeloma (45) High-risk Smoldering Myeloma (38) Late Relapse (4–6 Lines of Therapy) (84) MGUS (39) Newly Diagnosed (Pre-Treatment or First Treatment) (63) Smoldering Myeloma (49) Types of Therapy Immunomodulatory drugs (IMiDs) (60) Immunotherapies (CAR T; BiTE, etc.) (100) Monoclonal antibodies (54) Proteasome inhibitors (46) Stem cell transplant (38) Steroids (42) Supportive Care (43) Year Published 2026 (20) 2025 (32) 2024 (52) 2023 (43) 2022 (17) 2021 (12) 2020 (1) 2019 (10) 2018 (2) 2017 (1) 2016 (2) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (20) Dr. María-Victoria Mateos (7) Dr. Saad Usmani (3) Dr. Shaji Kumar (2) Dr. Sigurður Kristinsson (2) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (1) Donna Catamero, ANP-BC, OCN, CCRC (1) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance What is the IMWG and what is its purpose in the field of myeloma research? October 5, 2023 Ask Dr. Durie Myeloma Made Simple: Monoclonal Antibodies Made Simple | Approved Therapies For Myeloma Treatment August 31, 2023 Myeloma Made Simple Myeloma Made Simple: Drug Classes Made Simple | The Main Types of Drugs Used to Treat Myeloma July 27, 2023 Myeloma Made Simple What is the latest from the Black Swan Research Initiative? July 27, 2023 Ask Dr. Durie Myeloma University | Selinexor and Venetoclax; Two Drugs Used to Treat Myeloma in a Relapse Setting July 18, 2023 Myeloma University Phase 3, open-label, randomized trial comparing safety and efficacy of belamaf to Pd in RRMM: DREAMM-3 study July 10, 2023 ASCO/EHA CARTITUDE-1: Final results of Ciltacabtagene Autoleucel in heavily pretreated relapsed/refractory multiple myeloma July 7, 2023 ASCO/EHA Pivotal phase 2 MonumenTAL-1 results of talquetamab, a GPRC5DxCD3 bispecific antibody, for relapsed refractory multiple myeloma July 3, 2023 ASCO/EHA Quadruplet Induction Therapy, ASCT and MRD-modulated Consolidation and Treatment Cessation in Newly Diagnosed Multiple Myeloma July 1, 2023 ASCO/EHA Maintenance Therapy with Carfilzomib, Pomalidomide, and Dex (KPd) in High-Risk Myeloma Patients June 30, 2023 ASCO/EHA Updated Results of BCMA/CD19 Dual-targeting Fast CAR-T GC012F Dual-targeting CAR-T in RRMM June 30, 2023 ASCO/EHA Safety and Efficacy of elranatamab in RRMM & Prior BCMA Therapies: Analysis from MagnetisMM Studies June 29, 2023 ASCO/EHA Load More
